InvestorsHub Logo
Followers 118
Posts 11972
Boards Moderated 0
Alias Born 12/18/2003

Re: 3X Charm post# 163171

Monday, 05/03/2021 12:23:39 PM

Monday, May 03, 2021 12:23:39 PM

Post# of 233235
CD10 , didnt fail , We SS in extremely important NEWS 2 endpoints , we reduced over 80% progression from moderate to severe ..
Lenzilumab is proud with 54% , we did it with over 80%.

And in CD12 , we SS in length of hospitalization ,, almost 6 days for S/C , that's a lot..and we the only one reducing mortality , SS in many subgroups ..

But FDA didn't approve the protocol as they did for Remdesivir and Lenzilumg , where we too could " PICK "

If we could " PICK " we be SS in both.

And I hope ALL HERE know that.

" Know what you own " is a nice saying...

And as our friend like to say ...

..." Sleep Well Shorts "..

All IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News